Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 13 | 2019 | 384 | 3.540 |
Why?
|
| Bronchoscopy | 10 | 2018 | 56 | 2.120 |
Why?
|
| Pulmonary Medicine | 2 | 2015 | 11 | 1.050 |
Why?
|
| Endosonography | 2 | 2015 | 56 | 1.010 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2017 | 120 | 1.010 |
Why?
|
| Lymph Nodes | 2 | 2016 | 92 | 0.960 |
Why?
|
| Clinical Competence | 2 | 2015 | 307 | 0.850 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2019 | 93 | 0.790 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2018 | 50 | 0.760 |
Why?
|
| Decision Making | 2 | 2019 | 180 | 0.720 |
Why?
|
| Severity of Illness Index | 3 | 2017 | 863 | 0.680 |
Why?
|
| Serine Endopeptidases | 1 | 2018 | 19 | 0.670 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 33 | 0.670 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 48 | 0.650 |
Why?
|
| Decision Support Techniques | 1 | 2019 | 104 | 0.630 |
Why?
|
| Lymphoma | 1 | 2018 | 36 | 0.630 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2017 | 6 | 0.610 |
Why?
|
| Cough | 1 | 2017 | 19 | 0.600 |
Why?
|
| Granuloma | 1 | 2016 | 13 | 0.570 |
Why?
|
| Middle Aged | 15 | 2019 | 10834 | 0.540 |
Why?
|
| Postoperative Complications | 2 | 2017 | 670 | 0.520 |
Why?
|
| Asthma | 1 | 2017 | 397 | 0.460 |
Why?
|
| Mediastinal Diseases | 1 | 2012 | 4 | 0.450 |
Why?
|
| Aged | 11 | 2019 | 9492 | 0.440 |
Why?
|
| Biopsy, Needle | 1 | 2012 | 89 | 0.440 |
Why?
|
| Ultrasonography, Interventional | 1 | 2012 | 51 | 0.430 |
Why?
|
| Humans | 19 | 2019 | 29123 | 0.420 |
Why?
|
| Female | 15 | 2019 | 18173 | 0.410 |
Why?
|
| Male | 14 | 2019 | 17815 | 0.400 |
Why?
|
| Neoplasms | 1 | 2016 | 611 | 0.360 |
Why?
|
| Early Detection of Cancer | 3 | 2019 | 73 | 0.340 |
Why?
|
| Mass Screening | 2 | 2019 | 223 | 0.300 |
Why?
|
| Conscious Sedation | 2 | 2017 | 24 | 0.290 |
Why?
|
| Retrospective Studies | 5 | 2019 | 3112 | 0.290 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 787 | 0.250 |
Why?
|
| Neoplasm Staging | 2 | 2018 | 436 | 0.250 |
Why?
|
| Lymphatic Metastasis | 2 | 2016 | 156 | 0.240 |
Why?
|
| Academic Medical Centers | 2 | 2015 | 150 | 0.240 |
Why?
|
| Cohort Studies | 3 | 2018 | 1688 | 0.240 |
Why?
|
| Bronchial Neoplasms | 2 | 2013 | 5 | 0.210 |
Why?
|
| Cystatin A | 1 | 2019 | 8 | 0.170 |
Why?
|
| Interleukin-23 Subunit p19 | 1 | 2019 | 10 | 0.170 |
Why?
|
| Access to Information | 1 | 2019 | 12 | 0.170 |
Why?
|
| Antigens, Neoplasm | 1 | 2019 | 44 | 0.170 |
Why?
|
| Carcinoma, Bronchogenic | 1 | 2018 | 7 | 0.170 |
Why?
|
| Adult | 5 | 2018 | 8426 | 0.170 |
Why?
|
| RNA, Neoplasm | 1 | 2018 | 20 | 0.170 |
Why?
|
| Translocation, Genetic | 1 | 2018 | 17 | 0.170 |
Why?
|
| Clinical Protocols | 1 | 2018 | 95 | 0.160 |
Why?
|
| Decision Trees | 1 | 2018 | 23 | 0.160 |
Why?
|
| Prospective Studies | 3 | 2019 | 2021 | 0.160 |
Why?
|
| False Positive Reactions | 1 | 2017 | 25 | 0.160 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2017 | 8 | 0.150 |
Why?
|
| Cholinergic Antagonists | 1 | 2017 | 12 | 0.150 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2017 | 15 | 0.150 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 3719 | 0.150 |
Why?
|
| Vital Capacity | 1 | 2017 | 44 | 0.150 |
Why?
|
| Prednisolone | 1 | 2017 | 10 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 871 | 0.150 |
Why?
|
| Administration, Inhalation | 1 | 2017 | 92 | 0.150 |
Why?
|
| Forced Expiratory Volume | 1 | 2017 | 112 | 0.150 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2017 | 67 | 0.150 |
Why?
|
| Genotype | 1 | 2018 | 735 | 0.150 |
Why?
|
| Midazolam | 1 | 2016 | 11 | 0.150 |
Why?
|
| Respiratory Function Tests | 1 | 2017 | 111 | 0.150 |
Why?
|
| Anesthetics, Intravenous | 1 | 2016 | 17 | 0.140 |
Why?
|
| Fentanyl | 1 | 2016 | 33 | 0.140 |
Why?
|
| Mediastinum | 1 | 2016 | 12 | 0.140 |
Why?
|
| False Negative Reactions | 1 | 2016 | 21 | 0.140 |
Why?
|
| Bronchodilator Agents | 1 | 2017 | 82 | 0.140 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2016 | 47 | 0.140 |
Why?
|
| Biopsy | 1 | 2017 | 241 | 0.140 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2017 | 148 | 0.140 |
Why?
|
| Outpatients | 1 | 2015 | 49 | 0.130 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2015 | 9 | 0.130 |
Why?
|
| Lymphatic Diseases | 1 | 2014 | 9 | 0.130 |
Why?
|
| Mediastinal Neoplasms | 1 | 2014 | 13 | 0.130 |
Why?
|
| Palliative Care | 1 | 2015 | 47 | 0.130 |
Why?
|
| Case-Control Studies | 1 | 2017 | 859 | 0.130 |
Why?
|
| Leiomyoma | 2 | 2013 | 16 | 0.130 |
Why?
|
| Education, Medical, Graduate | 1 | 2014 | 116 | 0.120 |
Why?
|
| United States | 2 | 2019 | 3632 | 0.120 |
Why?
|
| Risk Assessment | 1 | 2019 | 1306 | 0.120 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 162 | 0.110 |
Why?
|
| Brain Neoplasms | 1 | 2019 | 587 | 0.110 |
Why?
|
| Cryotherapy | 1 | 2013 | 13 | 0.110 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 129 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 374 | 0.110 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 293 | 0.110 |
Why?
|
| Analysis of Variance | 1 | 2012 | 454 | 0.100 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 326 | 0.100 |
Why?
|
| Young Adult | 1 | 2018 | 2402 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2012 | 337 | 0.090 |
Why?
|
| Obesity | 1 | 2016 | 1063 | 0.090 |
Why?
|
| Feasibility Studies | 2 | 2019 | 263 | 0.080 |
Why?
|
| User-Computer Interface | 1 | 2019 | 34 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2019 | 96 | 0.040 |
Why?
|
| Internet | 1 | 2019 | 156 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2019 | 142 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 249 | 0.040 |
Why?
|
| Patient Selection | 1 | 2019 | 257 | 0.040 |
Why?
|
| Risk | 1 | 2017 | 289 | 0.040 |
Why?
|
| Survival Rate | 1 | 2019 | 795 | 0.040 |
Why?
|
| Oximetry | 1 | 2016 | 28 | 0.040 |
Why?
|
| Neck | 1 | 2016 | 26 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 301 | 0.030 |
Why?
|
| Research Design | 1 | 2017 | 286 | 0.030 |
Why?
|
| Prognosis | 1 | 2019 | 1362 | 0.030 |
Why?
|
| Radiation Dosage | 1 | 2015 | 72 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 353 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 2109 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2016 | 865 | 0.030 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2013 | 2 | 0.030 |
Why?
|
| Granular Cell Tumor | 1 | 2013 | 2 | 0.030 |
Why?
|
| Bronchial Diseases | 1 | 2013 | 5 | 0.030 |
Why?
|
| Papilloma | 1 | 2013 | 7 | 0.030 |
Why?
|
| Hamartoma | 1 | 2013 | 11 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2013 | 3101 | 0.020 |
Why?
|